Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$2M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| Open the original filing on SEC.gov |
| Sep 16 | HALO | Halozyme Therapeutics,… | SSELL◷ | 3,000 | $106.83 | $320.5K | -4.0% | Open the original filing on SEC.gov |
| Sep 16 | HALO | Halozyme Therapeutics,… | SSELL◷ | 3,100 | $106.13 | $329K | -4.0% | Open the original filing on SEC.gov |
| Jun 18 | NAUT | Nautilus Biotechnology,… | AGRANT◆ | 45,000 | — | — | — | Open the original filing on SEC.gov |
| May 5 | HALO | Halozyme Therapeutics,… | AGRANT◆ | 6,040 | — | — | — | Open the original filing on SEC.gov |
| May 5 | HALO | Halozyme Therapeutics,… | AGRANT | 3,796 | — | — | +5.1% | Open the original filing on SEC.gov |
| Jun 23, 2025 | NAUT | Nautilus Biotechnology,… | AGRANT◆ | 45,000 | — | — | — | Open the original filing on SEC.gov |
| May 1, 2025 | HALO | Halozyme Therapeutics,… | AGRANT◆ | 5,750 | — | — | — | Open the original filing on SEC.gov |
| May 1, 2025 | HALO | Halozyme Therapeutics,… | AGRANT | 4,165 | — | — | +6.0% | Open the original filing on SEC.gov |